DOCS
HealthcareDoximity, Inc. · Medical - Healthcare Information Services · $5B
What is Doximity, Inc.?
Doximity operates a cloud-based platform built exclusively for U.S. medical professionals, connecting physicians, nurses, and other clinicians across the country.
The platform lets clinicians collaborate with peers, coordinate patient care, and conduct virtual visits — all in one place. Revenue comes primarily from pharmaceutical manufacturers and healthcare systems that use Doximity's tools to reach and engage medical professionals at scale.
Incorporated in 2010 and headquartered in San Francisco, California, Doximity was formerly known as 3MD Communications, Inc.
- Clinician collaboration and messaging tools
- Telehealth and virtual patient visit capabilities
- Medical news and research feeds
- Career management resources for physicians
Is DOCS a Good Stock to Buy?
UQS Score rates DOCS as Very Good overall.
Doximity's Quality and Risk pillars both rank Strong, reflecting a business model that generates consistent returns with limited financial stress. Growth is rated Good, suggesting the platform continues to expand its reach among healthcare professionals.
The Moat pillar sits at Neutral, indicating the platform's competitive barriers are present but not yet considered dominant relative to sector peers.
See the exact pillar breakdown and full financial metrics by signing up for a Pro membership at UQS Score. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does DOCS pay dividends?
No — Doximity, Inc. does not currently pay a dividend.
Doximity does not currently pay a dividend. As a growth-oriented platform business, the company reinvests resources into expanding its clinician network and developing new tools rather than returning cash to shareholders through distributions.
When does DOCS report earnings?
Doximity reports earnings on a quarterly cadence, typical for US-listed equities.
The company's Strong Quality and Risk ratings suggest a track record of disciplined financial management. Growth has remained in positive territory, supported by demand from pharmaceutical and healthcare system clients.
For the most recent quarter's results, visit Doximity's investor relations page directly.
DOCS Price History
-70.5% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Doximity, Inc.?
Based on Doximity, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
Frequently Asked Questions
What does Doximity do?
Doximity runs a cloud-based platform designed for U.S. medical professionals. It lets clinicians collaborate, coordinate patient care, conduct virtual visits, and stay current with medical research — while generating revenue from pharmaceutical companies and healthcare systems.
Does DOCS pay dividends?
No, Doximity does not pay a dividend. The company focuses on reinvesting in platform growth rather than distributing cash to shareholders.
When does DOCS report earnings?
Doximity follows a standard quarterly earnings cadence. For the exact schedule and most recent results, check the investor relations section of Doximity's official website.
Is DOCS a good stock to buy?
UQS Score rates DOCS as Very Good, with Strong marks in Quality and Risk. Whether it fits your portfolio depends on your goals — the full pillar breakdown is available to Pro members at UQS Score.
Is DOCS overvalued?
The UQS Valuation pillar for DOCS is rated Good, suggesting the stock is not considered significantly stretched relative to its fundamentals. Full valuation metrics are available with a Pro membership.
What is DOCS's market cap bracket?
Doximity is classified as a mid-cap company, placing it between smaller growth-stage firms and the largest healthcare platform businesses.
Is DOCS a long-term quality indicator?
The UQS framework rates DOCS as Very Good, with Strong Quality and Risk scores — factors that often matter most over longer holding periods. Sustained moat development will be a key variable to watch going forward.
What sector does DOCS belong to?
Doximity operates in the Healthcare sector, specifically as a digital platform serving medical professionals, pharmaceutical manufacturers, and healthcare systems across the United States.
Unlock Full DOCS Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the complete UQS pillar score breakdown for DOCS
- ✓Access detailed financial metrics behind the Quality and Risk ratings
- ✓Compare DOCS against sector peers on every pillar
- ✓Get the full analyst view available exclusively to Pro members
Pro Analysis
DOCS — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | 20.0 | 0.0 | 58.0 | 0.0 | 36.9 | 0.0 | -44.2 |
| Aug 8, 2026 | 64.2 | 75.0 | 58.0 | 40.0 | 75.3 | 77.8 | -2.4 |
| Aug 6, 2026 | 66.6 | 80.0 | 58.0 | 40.0 | 82.4 | 78.2 | -2.8 |
| Aug 2, 2026 | 69.4 | 91.1 | 58.0 | 40.0 | 82.4 | 78.5 | +0.1 |
| Jul 31, 2026 | 69.3 | 91.1 | 58.0 | 40.0 | 82.4 | 77.9 | 0.0 |
| Jul 30, 2026 | 69.3 | 91.1 | 58.0 | 40.0 | 82.4 | 77.8 | -0.1 |
| Jul 28, 2026 | 69.4 | 91.1 | 58.0 | 40.0 | 82.4 | 78.2 | -8.5 |
| Jul 23, 2026 | 77.9 | 91.1 | 58.0 | 70.7 | 100.0 | 76.4 | +0.2 |
| Jul 22, 2026 | 77.7 | 91.1 | 58.0 | 70.7 | 100.0 | 75.0 | +0.3 |
| Jul 21, 2026 | 77.4 | 90.8 | 58.0 | 70.7 | 100.0 | 74.1 | -0.2 |
DOCS — Pillar Breakdown
Quality
— 0.0/100 (25%)Doximity, Inc. currently shows below-average quality metrics, suggesting challenges with profitability.
How effectively capital is deployed to generate returns.
Ability to convert revenue into operating profit.
Free cash flow relative to market value.
Growth
— 0.0/100 (20%)Doximity, Inc. faces growth headwinds with declining or stagnant revenue trends.
Revenue trajectory over the last twelve months.
Analyst consensus for future revenue growth.
Risk
— 36.9/100 (15%)Doximity, Inc. has some risk factors including moderate leverage or solvency concerns.
Debt levels relative to earnings capacity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 0.0/100 (15%)Doximity, Inc. appears expensively valued relative to its fundamentals and growth prospects.
Moat
— 58/100 (25%)Doximity, Inc. has meaningful competitive advantages that should protect its market position. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for DOCS.
Score Composition
Financial Data
More Stock Analysis
How is the DOCS UQS Score Calculated?
The UQS (Unified Quality Score) for Doximity, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Doximity, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Doximity, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.